A passive immunization treatment developed by Elan Corporation has already advanced to phase II clinical trials.

  • 伊蓝开发的一种被动免疫疗法,已进入第二阶段的临床试验.

  • 网络期刊摘选 2020-10-28 22:25:11

    • 相关例句